BEN
36
4
ITW
45
2
TMO
52
8
LEN
21
3
PFG
27
7
UAL
73
3
PNR
56
2
NTAP
58
3
IPG
43
3
OMC
37
2
NVDA
52
5
HIG
48
5
APA
30
5
CVS
27
2
SPG
45
2
MAR
57
3
GOOGL
62
6
AAP
26
5
WBA
41
3
HUM
25
4
BEN
36
4
ITW
45
2
TMO
52
8
LEN
21
3
PFG
27
7
UAL
73
3
PNR
56
2
NTAP
58
3
IPG
43
3
OMC
37
2
NVDA
52
5
HIG
48
5
APA
30
5
CVS
27
2
SPG
45
2
MAR
57
3
GOOGL
62
6
AAP
26
5
WBA
41
3
HUM
25
4
Financhill
Back

Ucloudlink Group 10K Form

Buy
53

UCL
Ucloudlink Group

Last Price:
$2.05
Seasonality Move:
-23.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UCL News And Ratings

See the #1 stock for the next 7 days that we like better than UCL

UCL Financial Statistics

Sales & Book Value

Annual Sales: $85.6M
Cash Flow: $2M
Price / Cash Flow: 10.6
Annual Sales: $0.60
Price / Book: 3.46

Profitability

EPS (TTM): 0.16260
Net Income (TTM): $4.2M
Gross Margin: $42M
Return on Equity: 22.69%
Return on Assets: 7.39%

Ucloudlink Group Earnings Forecast

Key Ucloudlink Group Financial Ratios

  • The Gross Profit Margin over the past 7 years for UCL is 49.04%.
  • The Selling, General & Administrative Expenses for UCL have been equal to 36.72% of Gross Profit Margin.
  • The Research & Development expenses have been 7.54% of Revenue.
  • The Interest Expense is 4.73% of Operating Income.
  • The Net Earning history of UCL is 3.28% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Ucloudlink Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Wireless Telecommunication Services
Sector: Communication Services
Current Symbol: UCL
Website: ucloudlink.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 1.4
Quick Ratio: 1.17

Price-to-Earnings

Trailing P/E Ratio: 20.7
Forward P/E Ratio: 2.92

UCL Technical Analysis vs Fundamental Analysis

Buy
53
Ucloudlink Group (UCL) is a Buy

Is Ucloudlink Group a Buy or a Sell?

  • Ucloudlink Group stock is rated a Buy
    The current Ucloudlink Group [UCL] share price is $2.07. The Score for UCL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.